These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5693061)

  • 1. Drug abuse: recommendations for California treatment and research facilities.
    Meyers FM; Smith DE
    Calif Med; 1968 Sep; 109(3):191-7. PubMed ID: 5693061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California's Proposition 36 on the treatment system and patient outcomes.
    Hser YI; Teruya C; Evans EA; Longshore D; Grella C; Farabee D
    Eval Rev; 2003 Oct; 27(5):479-505. PubMed ID: 14531316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends of drug abuse in Japan.
    Yamamoto J
    Ann N Y Acad Sci; 2004 Oct; 1025():430-8. PubMed ID: 15542746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social and legal factors related to drug abuse in the United States and Japan.
    Greberman SB; Wada K
    Public Health Rep; 1994; 109(6):731-7. PubMed ID: 7800780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions to problems of drug abuse in Zambia.
    Haworth A
    Bull Narc; 1983; 35(1):1-9. PubMed ID: 6555052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based prevention of substance abuse.
    De La Haye W
    West Indian Med J; 2004 Dec; 53(6):420-3. PubMed ID: 15816272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways to collaboration: exploring values and collaborative practice between child welfare and substance abuse treatment fields.
    Drabble L
    Child Maltreat; 2007 Feb; 12(1):31-42. PubMed ID: 17218646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Federal response to drug abuse.
    Heistad GT
    Minn Med; 1973 Mar; 56(3):187-91. PubMed ID: 4734613
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug abuse in Nepal: a rapid assessment study.
    Chatterjee A; Uprety L; Chapagain M; Kafle K
    Bull Narc; 1996; 48(1-2):11-33. PubMed ID: 9839033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.